Continuum Advisory, LLC Eli Lilly & CO Transaction History

Continuum Advisory, LLC

$778 Million
Q3 2024

A detailed history of Continuum Advisory, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Continuum Advisory, LLC holds 1,501 shares of LLY stock, worth $1.19 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

1,501

Previous 1,143 31.32%

Holding current value

$1.19 Million

Previous $1.03 Million 28.53%

% of portfolio

0.17%

Previous 0.15%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$772.14 - $960.02 $276,426 - $343,687	358 Added 31.32%	1,501 $1.33 Million
Q2 2024 Jul 19, 2024	SELL	$724.87 - $909.04 $2,174 - $2,727	-3 Reduced 0.26%	1,143 $1.03 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $38,493 - $51,498	-65 Reduced 5.37%	1,146 $891,000
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $23,633 - $27,860	-45 Reduced 3.58%	1,211 $705,000
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $124,324 - $171,399	-286 Reduced 18.55%	1,256 $674,000
Q2 2023 Dec 13, 2023	SELL	$350.74 - $468.98 $7,716 - $10,317	-22 Reduced 1.41%	1,542 $723,000
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $7,716 - $10,317	-22 Reduced 1.41%	1,542 $723,000
Q1 2023 Dec 13, 2023	BUY	$310.63 - $364.82 $61,504 - $72,234	198 Added 14.49%	1,564 $537,000
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $61,504 - $72,234	198 Added 14.49%	1,564 $537,000
Q4 2022 Dec 13, 2023	SELL	$321.55 - $374.67 $155,951 - $181,714	-485 Reduced 26.2%	1,366 $499,000
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $155,951 - $181,714	-485 Reduced 26.2%	1,366 $499,000
Q3 2022 Dec 13, 2023	BUY	$296.48 - $337.87 $5,336 - $6,081	18 Added 0.98%	1,851 $598,000
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $5,336 - $6,081	18 Added 0.98%	1,851 $598,000
Q2 2022 Dec 13, 2023	SELL	$278.73 - $327.27 $9,198 - $10,799	-33 Reduced 1.77%	1,833 $594,000
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $9,198 - $10,799	-33 Reduced 1.77%	1,833 $594,000
Q1 2022 Dec 13, 2023	BUY	$234.69 - $291.66 $181,180 - $225,161	772 Added 70.57%	1,866 $534,000
Q1 2022 May 17, 2022	BUY	$234.69 - $291.66 $181,180 - $225,161	772 Added 70.57%	1,866 $545,000
Q4 2021 Dec 13, 2023	SELL	$224.85 - $279.04 $1,349 - $1,674	-6 Reduced 0.55%	1,094 $302,000
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $1,349 - $1,674	-6 Reduced 0.55%	1,094 $302,000
Q3 2021 Dec 13, 2023	BUY	$221.6 - $272.71 $13,960 - $17,180	63 Added 6.08%	1,100 $254,000
Q3 2021 Nov 08, 2021	BUY	$221.6 - $272.71 $13,960 - $17,180	63 Added 6.08%	1,100 $254,000
Q2 2021 Dec 13, 2023	SELL	$180.55 - $233.54 $39,540 - $51,145	-219 Reduced 17.44%	1,037 $238,000
Q2 2021 Aug 17, 2021	BUY	$180.55 - $233.54 $187,230 - $242,180	1,037 New	1,037 $238,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.

Account

Continuum Advisory, LLC Eli Lilly & CO Transaction History